These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 27109485

  • 1. Application of histogram analysis for the evaluation of vascular permeability in glioma by the K2 parameter obtained with the dynamic susceptibility contrast method: Comparisons with Ktrans obtained with the dynamic contrast enhance method and cerebral blood volume.
    Taoka T, Kawai H, Nakane T, Hori S, Ochi T, Miyasaka T, Sakamoto M, Kichikawa K, Naganawa S.
    Magn Reson Imaging; 2016 Sep; 34(7):896-901. PubMed ID: 27109485
    [Abstract] [Full Text] [Related]

  • 2. Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis.
    Santarosa C, Castellano A, Conte GM, Cadioli M, Iadanza A, Terreni MR, Franzin A, Bello L, Caulo M, Falini A, Anzalone N.
    Eur J Radiol; 2016 Jun; 85(6):1147-56. PubMed ID: 27161065
    [Abstract] [Full Text] [Related]

  • 3. Dynamic susceptibility contrast and dynamic contrast-enhanced MRI characteristics to distinguish microcystic meningiomas from traditional Grade I meningiomas and high-grade gliomas.
    Hussain NS, Moisi MD, Keogh B, McCullough BJ, Rostad S, Newell D, Gwinn R, Foltz G, Mayberg M, Aguedan B, Good V, Fouke SJ.
    J Neurosurg; 2017 Apr; 126(4):1220-1226. PubMed ID: 27285539
    [Abstract] [Full Text] [Related]

  • 4. Glioma grading by microvascular permeability parameters derived from dynamic contrast-enhanced MRI and intratumoral susceptibility signal on susceptibility weighted imaging.
    Li X, Zhu Y, Kang H, Zhang Y, Liang H, Wang S, Zhang W.
    Cancer Imaging; 2015 Mar 21; 15(1):4. PubMed ID: 25889239
    [Abstract] [Full Text] [Related]

  • 5. Histogram analysis of T2*-based pharmacokinetic imaging in cerebral glioma grading.
    Liu HS, Chiang SW, Chung HW, Tsai PH, Hsu FT, Cho NY, Wang CY, Chou MC, Chen CY.
    Comput Methods Programs Biomed; 2018 Mar 21; 155():19-27. PubMed ID: 29512499
    [Abstract] [Full Text] [Related]

  • 6. Perfusion MRI grading diffuse gliomas: Impact of permeability parameters on molecular biomarkers and survival.
    Hilario A, Hernandez-Lain A, Sepulveda JM, Lagares A, Perez-Nuñez A, Ramos A.
    Neurocirugia (Astur : Engl Ed); 2019 Mar 21; 30(1):11-18. PubMed ID: 30143443
    [Abstract] [Full Text] [Related]

  • 7. Differentiating between Central Nervous System Lymphoma and High-grade Glioma Using Dynamic Susceptibility Contrast and Dynamic Contrast-enhanced MR Imaging with Histogram Analysis.
    Murayama K, Nishiyama Y, Hirose Y, Abe M, Ohyu S, Ninomiya A, Fukuba T, Katada K, Toyama H.
    Magn Reson Med Sci; 2018 Jan 10; 17(1):42-49. PubMed ID: 28515410
    [Abstract] [Full Text] [Related]

  • 8. Whole-tumor histogram analysis of the cerebral blood volume map: tumor volume defined by 11C-methionine positron emission tomography image improves the diagnostic accuracy of cerebral glioma grading.
    Wu R, Watanabe Y, Arisawa A, Takahashi H, Tanaka H, Fujimoto Y, Watabe T, Isohashi K, Hatazawa J, Tomiyama N.
    Jpn J Radiol; 2017 Oct 10; 35(10):613-621. PubMed ID: 28879406
    [Abstract] [Full Text] [Related]

  • 9. Comparative study of pulsed-continuous arterial spin labeling and dynamic susceptibility contrast imaging by histogram analysis in evaluation of glial tumors.
    Arisawa A, Watanabe Y, Tanaka H, Takahashi H, Matsuo C, Fujiwara T, Fujiwara M, Fujimoto Y, Tomiyama N.
    Neuroradiology; 2018 Jun 10; 60(6):599-608. PubMed ID: 29705876
    [Abstract] [Full Text] [Related]

  • 10. Differentiation of grade II and III oligodendrogliomas from grade II and III astrocytomas: a histogram analysis of perfusion parameters derived from dynamic contrast-enhanced (DCE) and dynamic susceptibility contrast (DSC) MRI.
    Lee JY, Ahn KJ, Lee YS, Jang JH, Jung SL, Kim BS.
    Acta Radiol; 2018 Jun 10; 59(6):723-731. PubMed ID: 28862024
    [Abstract] [Full Text] [Related]

  • 11. On the Use of DSC-MRI for Measuring Vascular Permeability.
    Skinner JT, Moots PL, Ayers GD, Quarles CC.
    AJNR Am J Neuroradiol; 2016 Jan 10; 37(1):80-7. PubMed ID: 26427833
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Permeability measurement using dynamic susceptibility contrast magnetic resonance imaging enhances differential diagnosis of primary central nervous system lymphoma from glioblastoma.
    Lee JY, Bjørnerud A, Park JE, Lee BE, Kim JH, Kim HS.
    Eur Radiol; 2019 Oct 10; 29(10):5539-5548. PubMed ID: 30877463
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Discrimination between glioma grades II and III in suspected low-grade gliomas using dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging: a histogram analysis approach.
    Falk A, Fahlström M, Rostrup E, Berntsson S, Zetterling M, Morell A, Larsson HB, Smits A, Larsson EM.
    Neuroradiology; 2014 Dec 10; 56(12):1031-8. PubMed ID: 25204450
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.